Bartlett & Co Wealth Management’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$112K Sell
1,829
-65
-3% -$5.13K ﹤0.01% 554
2025
Q4
$155K Sell
1,894
-275
-13% -$21.4K ﹤0.01% 487
2025
Q3
$163K Buy
2,169
+80
+4% +$5.97K ﹤0.01% 475
2025
Q2
$155K Buy
2,089
+151
+8% +$10.5K ﹤0.01% 474
2025
Q1
$156K Sell
1,938
-29
-1% -$2.49K ﹤0.01% 472
2024
Q4
$154K Buy
1,967
+4
+0.2% +$340 ﹤0.01% 480
2024
Q3
$184K Buy
1,963
+77
+4% +$6.46K ﹤0.01% 456
2024
Q2
$147K Sell
1,886
-30
-2% -$2.45K ﹤0.01% 481
2024
Q1
$174K Sell
1,916
-970
-34% -$80.7K ﹤0.01% 471
2023
Q4
$224K Buy
2,886
+366
+15% +$25.6K ﹤0.01% 457
2023
Q3
$171K Hold
2,520
﹤0.01% 466
2023
Q2
$205K Buy
2,520
+523
+26% +$41.7K ﹤0.01% 450
2023
Q1
$164K Buy
+1,997
New +$143K ﹤0.01% 403

Other funds holding GEHC

Bartlett & Co Wealth Management's GEHC Position: Q1 2026 in Review

Bartlett & Co Wealth Management reduced its GE HealthCare (GEHC) stake by 3.4% in Q1 2026, selling an estimated $5.13K and leaving 1,829 shares worth $112K. The position accounts for ﹤0.01% of the portfolio, ranked #554.

Bartlett & Co Wealth Management first reported a position in GEHC in Q1 2023 and has held it in 13 quarters since. The position peaked at $224K in Q4 2023. 1,263 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

  • Bartlett & Co Wealth Management held 1,829 shares of GE HealthCare worth $112K as of Q1 2026.
  • Bartlett & Co Wealth Management sold 65 GE HealthCare shares in Q1 2026, an estimated $5.13K.
  • GE HealthCare made up ﹤0.01% of Bartlett & Co Wealth Management's portfolio in Q1 2026, its #554 holding.
  • Bartlett & Co Wealth Management first reported a position in GE HealthCare in Q1 2023 and has held it in 13 quarters since.
  • Bartlett & Co Wealth Management's GE HealthCare position peaked at $224K in Q4 2023.
  • 1,263 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on Bartlett & Co Wealth Management's 13F filing for Q1 2026, filed 6 May 2026.